$AQU
Aquaron Acquisition Corp. Stock $aqu

$aqu Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024064071 Filed on August 01, 2024

Income Statement

Concept	2024 Q3	2024 Q1
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$351.5K	$89.88K
YoY Change	170.35%	-74.32%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$351.5K	$89.88K
YoY Change	170.35%	-74.32%
Operating Profit	-$351.4K	-$89.88K
YoY Change	175.81%	-74.53%
Interest Expense	$116.4K	$417.8K
YoY Change	-74.13%	-29.18%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$235.0K	$327.9K
YoY Change	-173.45%	36.64%
Income Tax	$22.61K	$84.44K
% Of Pretax Income		25.75%
Net Earnings	-$257.7K	$98.81K
YoY Change	-201.73%	-34.91%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.11	$0.02
COMMON SHARES
Basic Shares Outstanding	4.553M shares	4.553M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$109.7K	$27.70K
YoY Change	-99.65%	-99.95%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets	$165.0K	$0.00
YoY Change	-8.34%	-100.0%
Inventory
Prepaid Expenses	$20.25K
Receivables
Other Receivables
Total Short-Term Assets	$274.6K	$27.70K
YoY Change	-99.13%	-99.95%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$9.110M	$32.49M
YoY Change
Other Assets		$0.00
YoY Change
Total Long-Term Assets	$9.110M	$32.49M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$274.6K	$27.70K
Total Long-Term Assets	$9.110M	$32.49M
Total Assets	$9.384M	$32.52M
YoY Change	-70.16%	-42.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$384.0K	$85.77K
YoY Change	91.99%	-61.01%
Accrued Expenses	$22.30K	$29.29K
YoY Change	-25.67%	192.9%
Deferred Revenue
YoY Change
Short-Term Debt	$1.650M	$1.419M
YoY Change	117.06%	491.1%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.706M	$2.231M
YoY Change	-33.48%	-31.02%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.526M	$2.526M
YoY Change
Total Long-Term Liabilities	$2.526M	$2.526M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.706M	$2.231M
Total Long-Term Liabilities	$2.526M	$2.526M
Total Liabilities	$5.232M	$4.756M
YoY Change	28.61%	47.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.957M	-$4.729M
YoY Change	27.81%	-1618.23%
Common Stock	$163.00	$163.00
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.957M	-$4.729M
YoY Change
Total Liabilities & Shareholders Equity	$9.384M	$32.52M
YoY Change	-70.16%	-42.19%

Cashflow Statement

Concept	2024 Q3	2024 Q1
OPERATING ACTIVITIES
Net Income	-$257.7K	$98.81K
YoY Change	-201.73%	-34.91%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$130.8K	-$140.2K
YoY Change	86.89%	-48.68%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$80.00K	-$114.4K
YoY Change	-100.31%	-1244.2%
Cash From Investing Activities	-$80.00K	-$114.4K
YoY Change	-100.31%	-974.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	109.0K	$281.9K
YoY Change	-100.42%	17.48%
NET CHANGE
Cash From Operating Activities	-130.8K	-$140.2K
Cash From Investing Activities	-80.00K	-$114.4K
Cash From Financing Activities	109.0K	$281.9K
Net Change In Cash	-101.8K	$27.36K
YoY Change	69.7%	-236.54%
FREE CASH FLOW
Cash From Operating Activities	-$130.8K	-$140.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	AQUARON ACQUISITION CORP.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41470
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2760193
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	515 Madison Avenue
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	8th Floor
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
CY2024Q1	dei	City Area Code CityAreaCode	(646)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	970 2181
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	true
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4553150	shares
CY2024Q1	us-gaap	Cash Cash	27695	usd
CY2023Q4	us-gaap	Cash Cash	339	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2188	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	27695	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2527	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	144680	usd
CY2024Q1	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	32492503	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	31960267	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	32492503	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	32104947	usd
CY2024Q1	us-gaap	Assets Assets	32520198	usd
CY2023Q4	us-gaap	Assets Assets	32107474	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	85770	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	149045	usd
CY2024Q1	aqu	Franchise Tax Payable FranchiseTaxPayable	29294	usd
CY2023Q4	aqu	Franchise Tax Payable FranchiseTaxPayable	18495	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	437451	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	353013	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	259438	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	259438	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	630000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	490000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2230579	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1916669	usd
CY2024Q1	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2525896	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2525896	usd
CY2024Q1	us-gaap	Liabilities Liabilities	4756475	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4442565	usd
CY2024Q1	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	0.0001
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	0.0001
CY2024Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2930090	shares
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2930090	shares
CY2024Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2930090	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2930090	shares
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	32492503	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	31960268	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1623060	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1623060	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1623060	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1623060	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	163	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	163	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4728943	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4295522	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-4728780	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4295359	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32520198	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32107474	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	79082	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	340846	usd
CY2024Q1	us-gaap	Franchisor Costs FranchisorCosts	10800	usd
CY2023Q1	us-gaap	Franchisor Costs FranchisorCosts	12000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-89882	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-352846	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	274776	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	375656	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	143038	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	212381	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	327932	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	235191	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	84438	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46586	usd
CY2024Q1	aqu	Deferred Income Tax Benefit DeferredIncomeTaxBenefit	144680	usd
CY2023Q1	aqu	Deferred Income Tax Benefit DeferredIncomeTaxBenefit	36799	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	98814	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	151806	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4295359	usd
CY2024Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	532235	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	98814	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-4728780	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5298740	usd
CY2023Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	4135212	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	151806	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1315334	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	98814	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	151806	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	274776	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	375656	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	143038	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	212381	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	144680	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	36799	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2188	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-221	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-63276	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	80590	usd
CY2024Q1	aqu	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	10799	usd
CY2023Q1	aqu	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	-1086	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	84438	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	46586	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-140171	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-273121	usd
CY2024Q1	aqu	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount	140000	usd
CY2024Q1	aqu	Proceeds From Cash Withdrawn From Trust Account To Pay Taxes ProceedsFromCashWithdrawnFromTrustAccountToPayTaxes	25579	usd
CY2023Q1	aqu	Proceeds From Cash Withdrawn From Trust Account To Pay Taxes ProceedsFromCashWithdrawnFromTrustAccountToPayTaxes	13086	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-114421	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	13086	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	141948	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	240000	usd
CY2024Q1	aqu	Proceeds From Promissory Note Bestpath ProceedsFromPromissoryNoteBestpath	140000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	281948	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	240000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	27356	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-20035	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	339	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57284	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27695	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37249	usd
CY2024Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	532235	usd
CY2023Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	4135212	usd
CY2024Q1	aqu	Other Payable Due To Related Party OtherPayableDueToRelatedParty	97052	usd
CY2024Q1	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2021-03-11
CY2024Q1	aqu	Term Of Investment Maturity TermOfInvestmentMaturity	P185D
CY2024Q1	aqu	Aggregate Fair Market Value AggregateFairMarketValue	0.80	pure
CY2024Q1	aqu	Agreement Percentage AgreementPercentage	0.80	pure
CY2024Q1	aqu	Trust Account Balance TrustAccountBalance	0.80	pure
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5000001	usd
CY2024Q1	aqu	Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination	1	pure
CY2024Q1	us-gaap	Equity Fair Value Disclosure EquityFairValueDisclosure	1000000000	usd
CY2024Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10
CY2023Q2	us-gaap	Deposits Deposits	70000	usd
CY2024Q1	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	2487090	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	70000	usd
CY2024Q2	us-gaap	Deposits Deposits	20000	usd
CY2024Q1	aqu	Aggregate Shares Redemption AggregateSharesRedemption	2124738	shares
CY2024Q1	aqu	Share Redemption Value ShareRedemptionValue	23500000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	11.04
CY2024Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	50000	usd
CY2024Q1	aqu	Remaining Price Per Share RemainingPricePerShare	10.15
CY2024Q1	aqu	Trust Account Per Share TrustAccountPerShare	10.15
CY2024Q1	us-gaap	Cash Cash	27695	usd
CY2024Q1	aqu	Working Capital Deficit WorkingCapitalDeficit	2202884	usd
CY2024Q1	aqu	Payment From Sponsor PaymentFromSponsor	25000	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	300000	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	449780	usd
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	200000	usd
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	200000	usd
CY2023Q4	aqu	Conversion Outstanding ConversionOutstanding	97052	usd
CY2023	aqu	Transaction Cost TransactionCost	100000	usd
CY2022Q3	us-gaap	Derivative Average Forward Interest Rate DerivativeAverageForwardInterestRate	0.01	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.01	pure
CY2024Q1	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	259438	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these unaudited financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q1	us-gaap	Cash Cash	27695	usd
CY2023Q4	us-gaap	Cash Cash	339	usd
CY2024Q1	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	32492503	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	31960267	usd
CY2024Q1	us-gaap	Assets Held In Trust AssetsHeldInTrust	417814	usd
CY2023Q1	us-gaap	Assets Held In Trust AssetsHeldInTrust	588037	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.6987	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.3545	pure
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	158740	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	189253	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	174157	usd
CY2024Q1	aqu	Deferred Tax Assets Tax Amortization Of Startup Cost DeferredTaxAssetsTaxAmortizationOfStartupCost	3621	usd
CY2023Q4	aqu	Deferred Tax Assets Tax Amortization Of Startup Cost DeferredTaxAssetsTaxAmortizationOfStartupCost	2897	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	30038	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	29727	usd
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	155594	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	141533	usd
CY2024Q1	aqu	Valuation Allowance ValuationAllowance	155594	usd
CY2023Q4	aqu	Valuation Allowance ValuationAllowance	-3147	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	144680	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	98814	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	151806	usd
CY2024Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	532235	usd
CY2023Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	4135212	usd
CY2024Q1	aqu	Net Loss Including Accretion Of Common Stock To Redemption Value NetLossIncludingAccretionOfCommonStockToRedemptionValue	-433421	usd
CY2023Q1	aqu	Net Loss Including Accretion Of Common Stock To Redemption Value NetLossIncludingAccretionOfCommonStockToRedemptionValue	-3983406	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of March 31, 2024 and December 31, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p>
CY2024Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2024Q1	aqu	Common Stock Subject To Possible Redemption CommonStockSubjectToPossibleRedemption	532235	usd
CY2022Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	5000000	shares
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10
CY2022Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	12515.4	shares
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
CY2021Q2	aqu	Share Issued And Outstanding Percentage ShareIssuedAndOutstandingPercentage	0.20	pure
CY2024Q1	aqu	Subject To Certain Limited Exceptions Percentage SubjectToCertainLimitedExceptionsPercentage	0.50	pure
CY2023Q2	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	99846	usd
CY2024Q1	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	97052	usd
CY2023Q2	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	99846	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	0	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	97052	usd
CY2024Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	97052	usd
CY2024Q1	us-gaap	Notes Issued1 NotesIssued1	70000	usd
CY2024Q1	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	630000	usd
CY2023	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	490000	usd
CY2024Q1	aqu	Underwriters Option Period From The Date Of Initial Public Offering UnderwritersOptionPeriodFromTheDateOfInitialPublicOffering	P45Y
CY2024Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	750000	shares
CY2024Q1	aqu	Underwriter Cash Discount UnderwriterCashDiscount	812577	usd
CY2024Q1	aqu	Deferred Fee Per Unit DeferredFeePerUnit	3.5
CY2024Q1	aqu	Deferred Underwriting Commissions Payable DeferredUnderwritingCommissionsPayable	1896013	usd
CY2022Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	100	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	97509	shares
CY2022Q4	us-gaap	Percentage Of Weighted Average Cost Inventory PercentageOfWeightedAverageCostInventory	1.15	pure
CY2024Q1	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	1000000000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q1	aqu	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount		usd
CY2023Q1	aqu	Proceeds From Promissory Note Bestpath ProceedsFromPromissoryNoteBestpath		usd
CY2023Q1	aqu	Other Payable Due To Related Party OtherPayableDueToRelatedParty		usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001861063

Files In Submission

Name	View Source	Status
0001213900-24-064071-index-headers.html	Edgar Link	pending
0001213900-24-064071-index.html	Edgar Link	pending
0001213900-24-064071.txt	Edgar Link	pending
0001213900-24-064071-xbrl.zip	Edgar Link	pending
aqu-20240331.xsd	Edgar Link	pending
ea0209762-10q_aquaron.htm	Edgar Link	pending
ea0209762ex31-1_aquaron.htm	Edgar Link	pending
ea0209762ex31-2_aquaron.htm	Edgar Link	pending
ea0209762ex32-1_aquaron.htm	Edgar Link	pending
ea0209762ex32-2_aquaron.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
aqu-20240331_cal.xml	Edgar Link	unprocessable
aqu-20240331_def.xml	Edgar Link	unprocessable
aqu-20240331_lab.xml	Edgar Link	unprocessable
aqu-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0209762-10q_aquaron_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AQU
Aquaron Acquisition Corp. Stock $aqu

2024 Q3 Form 10-Q Financial Statement

#000121390024064071 Filed on August 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQU Aquaron Acquisition Corp. Stock $aqu

2024 Q3 Form 10-Q Financial Statement

#000121390024064071 Filed on August 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQU
Aquaron Acquisition Corp. Stock $aqu